THE ANTIEMETIC ACTIVITY OF HIGH-DOSE ALIZAPRIDE AND HIGH-DOSE METOCLOPRAMIDE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL

被引：23

作者：

JOSS, RA

GALEAZZI, RL

BISCHOFF, AK

PIROVINO, M

RYSSEL, HJ

BRUNNER, KW

机构：

[1] UNIV BERN,INST MED ONCOL,CH-3000 BERN,SWITZERLAND

[2] UNIV BERN,DEPT INTERNAL MED,CH-3000 BERN,SWITZERLAND

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1986年 / 39卷 / 06期

关键词：

D O I：

10.1038/clpt.1986.109

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：619 / 624

页数：6

共 22 条

[1] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].

AAPRO, MS ;

PLEZIA, PM ;

ALBERTS, DS ;

GRAHAM, V ;

JONES, SE ;

SURWIT, EA ;

MOON, TE .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471

[2]

BERMAN IJ, 1980, CANCER, V45, P764, DOI 10.1002/1097-0142(19800215)45:4<764::AID-CNCR2820450425>3.0.CO

[3]

2-G

[4] ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY [J].

BOWCOCK, SJ ;

STOCKDALE, AD ;

BOLTON, JAR ;

KANG, AA ;

RETSAS, S .

BRITISH MEDICAL JOURNAL, 1984, 288 (6434) :1879-1879

[5]

CLAVEL M, 1983, 4TH P NCI EORTC S NE

[6]

CUPISSOL D, 1982, SEM HOP PARIS, V58, P1370

[7] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].

GRALLA, RJ ;

ITRI, LM ;

PISKO, SE ;

SQUILLANTE, AE ;

KELSEN, DP ;

BRAUN, DW ;

BORDIN, LA ;

BRAUN, TJ ;

YOUNG, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909

[8] METOCLOPRAMIDE - A REVIEW OF ANTI-EMETIC TRIALS [J].

GRALLA, RJ .

DRUGS, 1983, 25 :63-73

[9] COMPARISON OF THE ANTIEMETIC EFFECT OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND HIGH-DOSE INTRAVENOUS HALOPERIDOL IN A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY [J].

GRUNBERG, SM ;

GALA, KV ;

LAMPENFELD, M ;

JAMIN, D ;

JOHNSON, K ;

CARIFFE, P ;

STRYCH, D ;

KRAILO, M .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :782-787

[10] CONTINUOUS INFUSION OF HIGH-DOSE METOCLOPRAMIDE FOR THE PREVENTION OF NAUSEA AND VOMITING IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].

JOSS, RA ;

GALEAZZI, RL ;

BRUNNER, KW .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (01) :35-39

← 1 2 3 →